Translational Development Acquisition Corp. Ordinary Shares
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Translational Development Acquisition Corp. Ordinary Shares (TDAC) - Total Assets
Latest total assets as of September 2025: $179.98 Million USD
Based on the latest financial reports, Translational Development Acquisition Corp. Ordinary Shares (TDAC) holds total assets worth $179.98 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Translational Development Acquisition Corp. Ordinary Shares - Total Assets Trend (2022–2024)
This chart illustrates how Translational Development Acquisition Corp. Ordinary Shares’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Translational Development Acquisition Corp. Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
Translational Development Acquisition Corp. Ordinary Shares's total assets of $179.98 Million consist of 0.4% current assets and 99.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $12.57 Trillion | 7182356.2% |
| Goodwill | $9.06 Trillion | 5178082.9% |
Asset Composition Trend (2022–2024)
This chart illustrates how Translational Development Acquisition Corp. Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Translational Development Acquisition Corp. Ordinary Shares's current assets represent 0.4% of total assets in 2024, a decrease from 12.4% in 2022.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2024, down from 0.5% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12360438.0% of total assets, an increase from 0.0% in 2022.
- Asset Diversification: The largest asset category is intangible assets at 7182356.2% of total assets.
Translational Development Acquisition Corp. Ordinary Shares Competitors by Total Assets
Key competitors of Translational Development Acquisition Corp. Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Translational Development Acquisition Corp. Ordinary Shares - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Translational Development Acquisition Corp. Ordinary Shares generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Translational Development Acquisition Corp. Ordinary Shares is currently not profitable relative to its asset base.
Translational Development Acquisition Corp. Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.19 | 0.23 | 0.61 |
| Quick Ratio | 0.19 | 0.23 | 0.61 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-342.26K | $ -740.36K | $ -40.30K |
Translational Development Acquisition Corp. Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Translational Development Acquisition Corp. Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 0.81 |
| Asset Growth Rate (YoY) | 8659008.3% |
| Total Assets | $175.00 Million |
| Market Capitalization | $142.14 Million USD |
Valuation Analysis
Near Book Valuation: The market values Translational Development Acquisition Corp. Ordinary Shares's assets close to their book value ( 0.81x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Translational Development Acquisition Corp. Ordinary Shares's assets grew by 8659008.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Translational Development Acquisition Corp. Ordinary Shares (2022–2024)
The table below shows the annual total assets of Translational Development Acquisition Corp. Ordinary Shares from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $175.00 Million | +8659008.31% |
| 2023-12-31 | $2.02K | -99.54% |
| 2022-12-31 | $437.24K | -- |